Post

New research · Infectious Disease
Chest · 23h
GuidelineChest · 2026

Management of Adult Bronchiectasis: An American College of Chest Physicians Clinical Practice Guideline.

Rachel Thomson, Christina Thornton, Timothy Aksamit … Lindsy Frazer-Green
Read paper
Infectious DiseaseGuideline

New guideline provides 13 recommendations for adult bronchiectasis management.

Management of Adult Bronchiectasis: An American College of Chest Physicians Clinical Practice Guideline.

Rachel Thomson et al. · Chest · 2026
Background

Bronchiectasis is a chronic respiratory condition involving a cycle of impaired mucociliary clearance, chronic infections, inflammation, and progressive airway destruction, leading to persistent cough with sputum production, dyspnea, and fatigue.

Purpose

Bronchiectasis research should aim to address many of the uncertainties in management, and priorities are identified within each PICO question.

Methods

An expert panel developed eight PICO-based questions addressing treatment of bronchiectasis in adults and conducted a systematic review.

n = 47 studies
Results
total guidance points for managing a chronic lung condition
n = 47 studies
“
Conclusion · 1 of 3

All recommendations are conditional, primarily based on low-certainty evidence. Bronchiectasis research should aim to address many of the uncertainties in management, and priorities are identified within each PICO question.

Conclusion · 2 of 3

Accurate phenotyping and endotyping may help guide therapeutic decision-making and risk stratification. Treatment interventions must consider potential treatment burdens, including cost, and impact on quality of life.

Conclusion · 3 of 3

Finally, shared decision-making with patients utilizing a multidisciplinary approach is paramount.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Study
77.8%
77.8% of patients achieved a strong reduction in hepatitis D virus RNA.
Cohort Study
100%
immediate bleeding control was achieved in all patients
Cohort Study
AHR, 1.09 [95% CI, 0.94-1.27]
similar risk of death for E. coli blood infections resistant vs susceptible to antibiotic
Study
90.5% (38/42)
most isolates were resistant to ampicillin and amoxicillin-sulbactam
Cohort Study
98%
nearly all refugee children received their missing childhood vaccines after arriving in Switzerland
Randomized Trial
33.3%
this percentage of participants experienced fatigue, the most common side effect
Cohort Study
182.1 per 100,000 population
this was the highest number of COVID-19 deaths per 100,000 food workers
Study
32-fold
removing the cfa gene made the bacteria much easier to kill with ampicillin